Surgery Bleeding Articles & Analysis
7 news found
To begin with, we plan to highlight last year’s NICE Medtech innovation briefing on the use of CytoSorb to reduce the risk of bleeding during cardiothoracic surgery in patients on blood thinning medications in the UK health system. ...
All bleeding events occurred after week 69 post-infusion. Two patients experienced bleeding events necessitating treatment with exogenous FVIII. ...
We are very pleased to enroll the first patient in the landmark STAR-T study that is investigating the ability of DrugSorb-ATR™ to remove ticagrelor during surgery and reduce the risk of bleeding in these patients. If positive, STAR-T could establish DrugSorb-ATR as an easily implemented solution that addresses a long-standing, frequent, and critical unmet ...
” In August 2021, the FDA granted CytoSorbents Breakthrough Device Designation to remove the Direct Oral Anticoagulants (DOACs) apixaban and rivaroxaban to reduce the risk of serious bleeding during urgent cardiothoracic surgery, recognizing this major unmet medical need. ...
TISSIUM’s vascular sealant is designed to address the issue of quickly achieving hemostasis and preventing post-operative bleeding following peripheral vascular surgeries, while also offering biocompatibility and a simple preparation and application process for surgeons. ...
ByTISSIUM
While building a platform technology, Russo directed Endomedix towards commercializing its first product, a gel spray that controls bleeding during ...
By relocating to the Newark-based university, the company has been able to tap into the institution’s human and financial resources, allowing it to keep costs at a minimum as it develops its product: a spray gel used to control bleeding during brain ...